-ptosis is a Greek-derived compound pathological suffix and substantive noun element in medical nomenclature that denotes the abnormal drooping, sagging, prolapse, downward displacement, or descent of an organ, tissue, or anatomical structure. Most prominently encountered in oculoplastic surgery and neuro-ophthalmology as blepharoptosis (the downward drooping of the upper eyelid covering the pupil, classified as senile/aponeurotic H02.431–H02.433, myogenic, neurogenic, mechanical, or congenital Q10.0), it also describes structural organ descent across plastic surgery (mastoptosis of the breast), urology (nephroptosis / floating kidney N28.89), gynecology (hysteroptosis / uterine prolapse N81.2–N81.4), and gastroenterology (gastroptosis, enteroptosis). In cellular pathology and molecular oncology, it also designates physiological and regulated programmed cell death pathways, most notably apoptosis (apo- [away] + ptosis [falling]). It is clinically and surgically paired with the procedural suffix -pexy (the surgical suspension or fixation of a ptotic organ). In 2026 medical coding, ptosis repairs (such as levator resection 67904 or Fasanella-Servat procedures 67908) are subjected to rigorous payer audit scrutiny to distinguish medically necessary functional vision restoration (requiring automated visual field testing and Margin Reflex Distance documentation) from non-covered cosmetic blepharoplasty (15823).
“a falling off or dropping away” — originally used in classical Greek literature to describe the shedding of autumn leaves or petals from trees.
In ancient Greek medicine, Hippocratic authors used ptōsis to describe the prolapse of viscera and ocular drooping. The term entered modern medical Latin and European anatomical treatises in the 18th and 19th centuries as ophthalmologists and surgeons developed precise corrective techniques for eyelid drooping (blepharoptosis). In 1972, John Kerr, Andrew Wyllie, and Alastair Currie resurrected the classical Greek term apoptosis to describe morphology-driven programmed cell clearance. The element belongs to the morphological root family of pt-, -pexy (the surgical remedy), -cele (herniation), and connects directly to clinical terms such as blepharoptosis, mastoptosis, nephroptosis, colpoptosis, and pyroptosis.
🔀 ALIASES / ALTERNATE TERMS
BLEPHAROPTOSIS(specific ophthalmic and oculoplastic term for upper eyelid drooping)
ORGAN PROLAPSE / DESCENSUS(general clinical synonym for downward anatomical displacement of pelvic or abdominal viscera)
MASTOPTEIC PTOSIS(plastic and reconstructive descriptor for breast tissue sagging)
DOWNWARD DISPLACEMENT / PTOTIC DEVIATION(pathological descriptor for gravitationally descended organs)
PROGRAMMED CELL DEATH(molecular and cellular pathology application seen in apoptosis, necroptosis, ferroptosis)
-cele — herniation, protrusion, or swelling of a tissue or organ (e.g., cystocele, rectocele); frequently coexists with or causes pelvic organ ptosis.
blepharoptosis — drooping of the upper eyelid caused by aponeurotic dehiscence, third nerve palsy, Horner syndrome, myasthenia gravis, or congenital dysgenesis (ICD-10-CM H02.401–H02.439, Q10.0).
dermatochalasis — excess, redundant, lax skin of the eyelid (ICD-10-CM H02.831–H02.839); frequently confused with or co-occurring with true myogenic/aponeurotic blepharoptosis.
mastoptosis — sagging or downward drooping of the female breast parenchyma and nipple-areolar complex due to loss of skin elasticity and Cooper’s ligament laxity (treated via mastopexy CPT 19316).
nephroptosis — abnormal downward displacement (“floating kidney”) of the kidney upon standing, often causing flank pain or hydronephrosis (ICD-10-CM N28.89).
visceroptosis — downward displacement or sagging of the abdominal internal organs (also termed splanchnoptosis or enteroptosis; K63.89).
hysteroptosis — uterine prolapse, descent of the uterus through the vaginal canal (ICD-10-CM N81.2–N81.4).
apoptosis — genetically regulated, energy-dependent programmed cell death characterized by cell shrinkage, chromatin condensation, and membrane blebbing.
Horner syndrome — oculosympathetic paresis characterized by the classic triad of unilateral ptosis, miosis, and anhidrosis (ICD-10-CM G90.2).
Sacrospinous ligament fixation for prolapse of vaginal vault
⚠️ Coding Note: In 2026 medical coding, surgical procedures correcting -ptosis (specifically upper eyelid blepharoptosis CPT 67900–67908) are among the most heavily audited services across Medicare and commercial payers due to frequent confusion with cosmetic blepharoplasty (CPT 15823):
Functional Medical Necessity Requirements for Ptosis Repair: To establish medical necessity for reconstructive ptosis repair, clinical documentation must satisfy three strict objective criteria: (a) automated visual field (Humphrey/Goldmann) demonstrating at least ≥30% or ≥12 degrees of superior visual field loss in the primary position; (b) visual field improvement to normal limits when the lid is taped; and (c) external photographs documenting a Margin Reflex Distance 1 (MRD-1) of ≤2.0 mm or the eyelid margin resting within 1 mm of the pupillary center.
Modifier Selection: When performing eyelid surgery, always append eyelid-specific modifiers: -E1 (upper left), -E2 (lower left), -E3 (upper right), and -E4 (lower right). For bilateral blepharoptosis repair, append Modifier -50 or report bilateral lines with -E3 and -E1 depending on specific commercial payer policies.
Concurrent Blepharoptosis Repair & Blepharoplasty: When both true ptosis repair (CPT 67904) and upper blepharoplasty for dermatochalasis (CPT 15823) are performed on the same eye, medical documentation must clearly demonstrate distinct surgical indications and approaches. While CPT allows both with Modifier -59 or Modifier -XS, many payers bundle the excision of redundant skin into the ptosis repair unless extensive skin resection is independently justified.
Mastopexy Coverage: Mastopexy (CPT 19316) for breast ptosis is considered cosmetic by Medicare and commercial payers unless performed as part of post-mastectomy breast reconstruction on the contralateral breast to achieve symmetry under the Women’s Health and Cancer Rights Act (WHCRA).